Showing results (41-50 of 295) with videos related to
Sort By:
Pageof 30
Cells|December 30, 2020
Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell ImmunotherapyMarsha Pellegrino, Francesca Del Bufalo, Biagio De Angelis, et al.Current Cancer Drug Targets|October 8, 2003
Genes and proteins governing the cellular sensitivity to HSP90 inhibitors: a mechanistic perspectiveAlison Maloney, Paul A Clarke, Paul WorkmanTrends in Biotechnology|April 3, 2009
Structure-based design of molecular cancer therapeuticsRob L M van Montfort, Paul WorkmanCancer Cell|May 19, 2010
Unveiling the secrets of the ancestral PI3 kinase Vps34Paul Workman, Rob L M van MontfortMolecular Oncology|March 24, 2012
Discovery of small molecule cancer drugs: successes, challenges and opportunitiesSwen Hoelder, Paul A Clarke, Paul WorkmanEssays in Biochemistry|November 10, 2017
Structure-based drug design: aiming for a perfect fitRob L M van Montfort, Paul WorkmanBreast Cancer Research : BCR|July 9, 2002
Finding the needle in the haystack: why high-throughput screening is good for your healthG Wynne Aherne, Edward McDonald, Paul WorkmanNature Biotechnology|July 12, 2012
Combinatorial drug therapy for cancer in the post-genomic eraBissan Al-Lazikani, Udai Banerji, Paul WorkmanThe Biochemical Journal|February 23, 2008
The Hsp90 molecular chaperone: an open and shut case for treatmentLaurence H Pearl, Chrisostomos Prodromou, Paul WorkmanCancers|August 27, 2021
PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic ApproachesMatteo Caforio, Emmanuel de Billy, Biagio De Angelis, et al.Pageof 30